An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
AngioDynamics to Present at Three Investor Conferences in March
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AngioDynamics, Inc. (NASDAQ: ANGO) announced that President and CEO Jim Clemmer and CFO Stephen Trowbridge will present at three investor conferences in March 2022. The conferences include:
Oppenheimer Virtual Healthcare Conference: March 15, 2022, at 8:40 a.m. ET
Barclays Global Healthcare Conference: March 16, 2022, in Miami Beach, FL, at 9:00 a.m. ET
KeyBanc Virtual Life Sciences & MedTech Investor Forum: March 22, 2022, at 3:45 p.m. ET
Live webcasts will be available on the company's website.
Positive
None.
Negative
None.
LATHAM, N.Y.--(BUSINESS WIRE)--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the following three investor conferences in March:
Conference: Oppenheimer Virtual Healthcare Conference Date: Tuesday, March 15, 2022 Presentation: 8:40 a.m. ET
Conference: Barclays Global Healthcare Conference Location: Miami Beach, FL Date: Wednesday, March 16, 2022 Presentation: 9:00 a.m. ET
Conference: KeyBanc Virtual Life Sciences & MedTech Investor Forum Date: Tuesday, March 22, 2022 Presentation: 3:45 p.m. ET
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.
AngioDynamics, Inc. Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
What are the upcoming investor conferences for AngioDynamics in March 2022?
AngioDynamics will present at the Oppenheimer Virtual Healthcare Conference on March 15 at 8:40 a.m. ET, the Barclays Global Healthcare Conference on March 16 in Miami Beach at 9:00 a.m. ET, and the KeyBanc Virtual Life Sciences & MedTech Investor Forum on March 22 at 3:45 p.m. ET.
Where can I watch the AngioDynamics investor presentations?
You can watch the live webcasts of AngioDynamics' investor presentations on their website under the 'Investors' section.
Who will represent AngioDynamics at the March 2022 investor conferences?
Jim Clemmer, President and CEO, and Stephen Trowbridge, Executive Vice President and CFO, will represent AngioDynamics at the conferences.
